[Effect of the direct healthcare professional communication on citalopram and escitalopram drug utilization for inpatient treatment of anxiety disorders].

Köberle U, Grohmann R, Belz M, Greil W, Degner D

Open source

DOI
10.1007/s00103-022-03594-z
Published
2022 Nov
Container
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00103-022-03594-z,
  title = {[Effect of the direct healthcare professional communication on citalopram and escitalopram drug utilization for inpatient treatment of anxiety disorders].},
  author = {Köberle U and Grohmann R and Belz M and Greil W and Degner D},
  year = {2022},
  journal = {Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz},
  doi = {10.1007/s00103-022-03594-z},
  url = {https://doi.org/10.1007/s00103-022-03594-z}
}

RIS

TY  - JOUR
TI  - [Effect of the direct healthcare professional communication on citalopram and escitalopram drug utilization for inpatient treatment of anxiety disorders].
AU  - Köberle U
AU  - Grohmann R
AU  - Belz M
AU  - Greil W
AU  - Degner D
PY  - 2022
JO  - Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
DO  - 10.1007/s00103-022-03594-z
UR  - https://doi.org/10.1007/s00103-022-03594-z
ER  - 

APA

U, K., R, G., M, B., W, G., & D, D. (2022). [Effect of the direct healthcare professional communication on citalopram and escitalopram drug utilization for inpatient treatment of anxiety disorders].. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. https://doi.org/10.1007/s00103-022-03594-z

Source records